KR20090113477A - 항고혈압활성 락토바실러스 플란타룸 및 이를 포함하는발효물 - Google Patents
항고혈압활성 락토바실러스 플란타룸 및 이를 포함하는발효물 Download PDFInfo
- Publication number
- KR20090113477A KR20090113477A KR1020080039215A KR20080039215A KR20090113477A KR 20090113477 A KR20090113477 A KR 20090113477A KR 1020080039215 A KR1020080039215 A KR 1020080039215A KR 20080039215 A KR20080039215 A KR 20080039215A KR 20090113477 A KR20090113477 A KR 20090113477A
- Authority
- KR
- South Korea
- Prior art keywords
- lactobacillus
- lactic acid
- lactobacillus plantarum
- acid bacteria
- nuc
- Prior art date
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 39
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 21
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 21
- 230000003276 anti-hypertensive effect Effects 0.000 title description 9
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 64
- 241000894006 Bacteria Species 0.000 abstract description 33
- 239000004310 lactic acid Substances 0.000 abstract description 33
- 235000014655 lactic acid Nutrition 0.000 abstract description 32
- 239000002253 acid Substances 0.000 abstract description 10
- 239000006041 probiotic Substances 0.000 abstract description 9
- 230000000529 probiotic effect Effects 0.000 abstract description 9
- 235000018291 probiotics Nutrition 0.000 abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 6
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 abstract description 5
- 239000003613 bile acid Substances 0.000 abstract description 5
- 241000269908 Platichthys flesus Species 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 238000012258 culturing Methods 0.000 abstract 2
- 235000013311 vegetables Nutrition 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 20
- 241000186660 Lactobacillus Species 0.000 description 17
- 230000036772 blood pressure Effects 0.000 description 16
- 229940039696 lactobacillus Drugs 0.000 description 16
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 11
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 11
- 206010020772 Hypertension Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 235000013618 yogurt Nutrition 0.000 description 10
- 235000012000 cholesterol Nutrition 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 7
- 108010082126 Alanine transaminase Proteins 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 241000700159 Rattus Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000021107 fermented food Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229940057059 monascus purpureus Drugs 0.000 description 5
- 108010010234 HDL Lipoproteins Proteins 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000004051 gastric juice Anatomy 0.000 description 4
- 239000008176 lyophilized powder Substances 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 235000013322 soy milk Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 239000005541 ACE inhibitor Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 2
- 235000019730 animal feed additive Nutrition 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 235000021109 kimchi Nutrition 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 230000001698 pyrogenic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000028185 Angioedema Diseases 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 108010061435 Enalapril Proteins 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 101000637031 Homo sapiens Trafficking protein particle complex subunit 9 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000935974 Paralichthys dentatus Species 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 102100031926 Trafficking protein particle complex subunit 9 Human genes 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- -1 alpharutin Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 229960000873 enalapril Drugs 0.000 description 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100001092 no hepatotoxicity Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229960003401 ramipril Drugs 0.000 description 1
- HDACQVRGBOVJII-JBDAPHQKSA-N ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 description 1
- 229940026314 red yeast rice Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000006411 tonic activation Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 235000020255 yak milk Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Groups | Total cholesterol (mg/dL) | Triglyceride (mg/dL) | HDL cholesterol (mg/dL) |
대조구 (유산균 무섭취) | 61.89±2.911) NS | 74.22±3.63NS | 36.23±5.56bc |
비교유산균 L. plantarum LG8(107CFU/ml) | 57.54±4.61 | 67.85±3.94 | 46.52±12.55abc |
비교유산균 L. plantarum LG8(109CFU/ml) | 59.51±3.22 | 69.23±4.38 | 48.76±3.15a |
L. plantarum NUC-LG42 (107CFU/ml) | 58.72±4.96 | 70.30±5.27 | 49.78±1.44a |
L. plantarum NUC-LG42 (109CFU/ml) | 58.50±1.95 | 67.32±3.37 | 47.19±12.41ab |
Groups | AST (IU/L) | ALT (IU/L) |
대조구 (유산균 무섭취) | 108.78±24.681) abc | 56.27±6.86bc |
비교유산균 L. plantarum LG8(107CFU/ml) | 109.27±20.83abc | 57.11±11.06c |
비교유산균 L. plantarum LG8(109CFU/ml) | 91.95±2.88cd | 56.91±7.52bc |
L. plantarum NUC-LG42 (107CFU/ml) | 94.74±11.58bcd | 66.50±9.59a |
L. plantarum NUC-LG42 (109CFU/ml) | 110.06±32.92a | 60.73±15.09bc |
Claims (3)
- 락토바실러스 플란타룸 NUC-LG42 KCCM 10940P 균주.
- 청구항 1에 기재된 균주를 이용한 배양물.
- 청구항 1에 기재된 균주를 포함하는 발효 제품.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080039215A KR101010913B1 (ko) | 2008-04-28 | 2008-04-28 | 항고혈압활성 락토바실러스 플란타룸 및 이를 포함하는 발효물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080039215A KR101010913B1 (ko) | 2008-04-28 | 2008-04-28 | 항고혈압활성 락토바실러스 플란타룸 및 이를 포함하는 발효물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090113477A true KR20090113477A (ko) | 2009-11-02 |
KR101010913B1 KR101010913B1 (ko) | 2011-01-26 |
Family
ID=41554801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080039215A KR101010913B1 (ko) | 2008-04-28 | 2008-04-28 | 항고혈압활성 락토바실러스 플란타룸 및 이를 포함하는 발효물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101010913B1 (ko) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016027964A1 (ko) * | 2014-08-22 | 2016-02-25 | (주)에이투젠 | 항염증 및 대사성질환 개선 효능을 가지는 락토바실러스 플란타룸 hac01 균주 및 이의 용도 |
WO2017077286A1 (en) * | 2015-11-02 | 2017-05-11 | Optibiotix Ltd | Composition comprising lactobacillus plantarum 2830 (ecgc 13110402) |
KR20200110098A (ko) * | 2019-03-13 | 2020-09-23 | 강원대학교산학협력단 | 항고혈압 활성 펩타이드를 생성하는 유산균 |
KR20240066518A (ko) | 2022-11-03 | 2024-05-16 | 한국식품연구원 | Ace 억제 활성을 갖는 신규한 락티플란티바실러스 플란타럼 k79 균주, 이를 이용한 우유 발효물의 제조방법, 이에 따른 우유 발효물 및 이를 유효성분으로 포함하는 고혈압의 예방 또는 개선용 식품 조성물 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102209870B1 (ko) | 2019-03-13 | 2021-02-03 | 강원대학교산학협력단 | 항고혈압 활성 펩타이드, 그의 제조방법 및 그의 용도 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100264361B1 (ko) * | 1998-04-03 | 2000-08-16 | 남승우 | 콜레스테롤 저하능을 가지는 락토바실러스 플란타룸 pmo08(kfcc-11028)미생물 |
-
2008
- 2008-04-28 KR KR1020080039215A patent/KR101010913B1/ko active IP Right Grant
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016027964A1 (ko) * | 2014-08-22 | 2016-02-25 | (주)에이투젠 | 항염증 및 대사성질환 개선 효능을 가지는 락토바실러스 플란타룸 hac01 균주 및 이의 용도 |
US10405569B2 (en) | 2014-08-22 | 2019-09-10 | Atogen Co., Ltd. | Lanctobacillus plantarum HAC01 strain having anti-inflammatory efficacy and metabolic disease alleviating efficacy and use thereof |
WO2017077286A1 (en) * | 2015-11-02 | 2017-05-11 | Optibiotix Ltd | Composition comprising lactobacillus plantarum 2830 (ecgc 13110402) |
JP2018535940A (ja) * | 2015-11-02 | 2018-12-06 | オプティバイオティクス リミテッド | ラクトバチルス・プランタルム2830(ecgc13110402)を含む組成物 |
US11413317B2 (en) | 2015-11-02 | 2022-08-16 | Probiotix Health Limited | Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402) |
US11903979B2 (en) | 2015-11-02 | 2024-02-20 | Probiotix Health Limited | Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402) |
KR20200110098A (ko) * | 2019-03-13 | 2020-09-23 | 강원대학교산학협력단 | 항고혈압 활성 펩타이드를 생성하는 유산균 |
KR20240066518A (ko) | 2022-11-03 | 2024-05-16 | 한국식품연구원 | Ace 억제 활성을 갖는 신규한 락티플란티바실러스 플란타럼 k79 균주, 이를 이용한 우유 발효물의 제조방법, 이에 따른 우유 발효물 및 이를 유효성분으로 포함하는 고혈압의 예방 또는 개선용 식품 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR101010913B1 (ko) | 2011-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6303161B1 (en) | Product containing healthful component and process for preparing the same | |
CN105249100B (zh) | 发酵果蔬汁与甜酒酿复合功能饮料的生产方法 | |
KR101680014B1 (ko) | 김치로부터 분리한 염증성 장 질환 치료 효과를 갖는 유산균 | |
CN109042881B (zh) | 运动型发酵乳制品及制备方法 | |
KR20060135016A (ko) | 유카 추출물, 퀼라야 추출물 및 유산균을 포함하는 조성물및 상기 조성물을 함유하는 음식물 | |
US20090285936A1 (en) | New functional fermented milk (yogurt) for use in dieting | |
KR102121826B1 (ko) | 간 기능 개선용 유산균 및 이의 용도 | |
Kumar Mishra et al. | Biofunctional attributes and storage study of soy milk fermented by Lactobacillus rhamnosus and Lactobacillus helveticus | |
CN101564133A (zh) | 一种豆酸奶及其制造方法 | |
EP2615928B1 (en) | Method of production of fermented, pro-healthy, cereal beverages | |
KR101010913B1 (ko) | 항고혈압활성 락토바실러스 플란타룸 및 이를 포함하는 발효물 | |
CN101744048A (zh) | 一种纳豆酸奶及其制备方法 | |
JP3644500B2 (ja) | キノコ乳酸発酵液の製造方法及びそれから製造されるキノコ乳酸発酵液(amethodforpreparingalacticacidfermentedsolutionofmushroomandlacticacidfermentedsolutionofmushroomproducedthereby) | |
KR102005617B1 (ko) | 항콜레스테롤 활성이 우수한 신규 락토바실러스 플란타룸 f.m.b #31 균주 및 이의 용도 | |
KR101884634B1 (ko) | 체중 조절 효과를 지닌 유산균 발효액 | |
KR101238836B1 (ko) | 혼합 유산균을 포함하는 비만 또는 비만 관련 질환 치료 또는 예방용 약제학적 조성물 또는 식품 조성물 | |
JP2009125055A (ja) | ビフィズス菌および乳酸菌の増殖促進剤 | |
JP5422200B2 (ja) | 肝機能障害改善剤 | |
KR101828494B1 (ko) | 유산균을 이용한 발효음료의 제조방법 | |
KR100769299B1 (ko) | 알코올 분해능이 있는 유산균 및 그를 함유하는 유제품, 건강 기능성 식품 및 식품 첨가제 | |
JP2010209015A (ja) | 抗アレルギー用組成物及びそれを含有する抗アレルギー剤および抗アレルギー食品 | |
TWI766184B (zh) | 一種植物乳桿菌及其製備植物性凝態優格、改善腸道菌相的用途 | |
Kaur et al. | Role of fermented dairy foods in human health | |
CN113229365A (zh) | 一种有助于改善肠道菌群与助睡眠的酸奶及其制备方法 | |
CN113908182B (zh) | 发酵沙棘汁及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140106 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150112 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160119 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20161230 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180105 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20181123 Year of fee payment: 9 |